Volume 87 Issue 35 | p. 17 | Concentrates
Issue Date: August 31, 2009

Astellas To Add Fermentation Unit

Department: Business
Keywords: clinical trial, Astellas Pharma

Japan’s Astellas Pharma has started construction of a $58 million fermentation unit in Toyama, in western Japan. The new unit will be able to produce multiple types of active drug ingredients for use in clinical trials and will also support the company’s process development efforts. The firm has several drug candidates at the preclinical stage that have been obtained at least partly through fermentation of natural substances. Simultaneously, Astellas says it will restructure its R&D activities and transfer drug discovery work from its fermentation research center to its pharmacology and molecular medicine labs. It plans to construct a new fermentation research building in Tsukuba by the end of 2011 and will create a bioimaging research lab, also in Tsukuba.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment